Vabomere
NDC Package 65293-009-06
Package Information
Vabomere is a medication used to treat a variety of bacterial infections. Marketed by The Medicines Company, this product is identified by NDC 65293-009 and is authorized under FDA application NDA209776.
Identification & Billing
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 65293 - The Medicines Company
- 65293-009 - Vabomere
- 65293-009-06 - 6 VIAL, SINGLE-DOSE in 1 CARTON / 2 g in 1 VIAL, SINGLE-DOSE (65293-009-01)
- 65293-009 - Vabomere
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 65293-009-06 identifies a specific commercial package of 6 vial, single-dose in 1 carton / 2 g in 1 vial, single-dose (65293-009-01) of Vabomere, labeled by The Medicines Company. This product is billed for "EA" each discreet unit and contains an estimated amount of 1 billable units per package. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by The Medicines Company on October 02, 2017. The current certification is valid through July 31, 2019.
What are the primary indications for this medication?
This product is used to treat a variety of bacterial infections. It contains 2 different medications: meropenem and vaborbactam. Meropenem is a carbapenem-type antibiotic that works by stopping the growth of bacteria. Vaborbactam is an enzyme inhibitor (beta-lactamase inhibitor) that helps meropenem work better.
How is this The Medicines Company product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 65293000906. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 1 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.